Endoxan 500 mg

DRUG2 trials

Sponsors

AstraZeneca AB, Universitair Ziekenhuis Gent

Conditions

Large B-cell LymphomaPatients undergoing Fludarabine based lymphodepletion prior to CAR-T cell therapyfor hematological malignancy

Phase 3

A Phase III, Multicentre, Open-Label, Randomised Study Evaluating the Efficacy and Safety of R-mini-CHOP x2 followed by AZD0486 versus R-mini-CHOP x6 in Elderly or Unfit Participants with Newly Diagnosed Large B-cell Lymphoma (SOUNDTRACK-D2)

Not yet recruitingCTIS2025-522029-37-00

AstraZeneca ABLarge B-cell Lymphoma

Target: 14Updated: 2026-01-30

Phase 4

Fludarabine exposure in patients undergoing Fludarabine based lymphodepletion prior to CAR-T cell therapy

Not yet recruitingCTIS2025-524278-40-00

Universitair Ziekenhuis Gentfor hematological malignancy, Patients undergoing Fludarabine based lymphodepletion prior to CAR-T cell therapy

Target: 75Updated: 2026-03-23